- Home
- TCMD vs BDTX Comparison
TCMD vs BDTX Comparison
Compare TCMD & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- BDTX
- Stock Information
- Founded
- TCMD 1995
- BDTX 2014
- Country
- TCMD United States
- BDTX United States
- Employees
- TCMD N/A
- BDTX N/A
- Industry
- TCMD Medical/Dental Instruments
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCMD Health Care
- BDTX Health Care
- Exchange
- TCMD Nasdaq
- BDTX Nasdaq
- Market Cap
- TCMD 236.4M
- BDTX 132.5M
- IPO Year
- TCMD 2016
- BDTX 2020
- Fundamental
- Price
- TCMD $10.13
- BDTX $2.60
- Analyst Decision
- TCMD Hold
- BDTX Strong Buy
- Analyst Count
- TCMD 3
- BDTX 6
- Target Price
- TCMD $16.00
- BDTX $14.83
- AVG Volume (30 Days)
- TCMD 239.8K
- BDTX 1.3M
- Earning Date
- TCMD 08-04-2025
- BDTX 08-05-2025
- Dividend Yield
- TCMD N/A
- BDTX N/A
- EPS Growth
- TCMD N/A
- BDTX N/A
- EPS
- TCMD 0.66
- BDTX 0.09
- Revenue
- TCMD $293,164,000.00
- BDTX $70,000,000.00
- Revenue This Year
- TCMD $7.96
- BDTX N/A
- Revenue Next Year
- TCMD $8.53
- BDTX N/A
- P/E Ratio
- TCMD $15.39
- BDTX $28.15
- Revenue Growth
- TCMD 5.96
- BDTX N/A
- 52 Week Low
- TCMD $8.61
- BDTX $1.20
- 52 Week High
- TCMD $21.10
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- TCMD 45.96
- BDTX 61.72
- Support Level
- TCMD $9.91
- BDTX $2.34
- Resistance Level
- TCMD $10.52
- BDTX $2.71
- Average True Range (ATR)
- TCMD 0.30
- BDTX 0.18
- MACD
- TCMD 0.08
- BDTX -0.01
- Stochastic Oscillator
- TCMD 45.83
- BDTX 79.65
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.